Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Advances in Experimental Medicine and Biology
|
January 1, 1997
Effects of 13-HODE and other momohydroxides on integrin/ligand binding: implications for cell cell interactions
M R Buchanan, S J Brister
Seminars in Thrombosis and Hemostasis
|
January 1, 1993
Altering vessel wall fatty acid metabolism: a new strategy for antithrombotic treatment
M R Buchanan, S J Brister
Thrombosis Research
|
September 7, 2000
Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist
M R Buchanan, S J Brister
Wiener Klinische Wochenschrift
|
March 27, 1999
A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding
M R Buchanan, S J Brister
Journal of Cardiothoracic and Vascular Anesthesia
|
June 1, 1995
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate
S J Brister, M R Buchanan
The Canadian Journal of Cardiology
|
December 1, 2001
Sex-related differences in the pathophysiology of cardiovascular disease: is there a rationale for sex-related treatments?
M R Buchanan, S J Brister
The Canadian Journal of Cardiology
|
January 28, 1998
Revascularization options
S J Brister, R G MacDonald
Advances in Experimental Medicine and Biology
|
January 1, 1997
Effects of linoleic acid and/or marine fish oil supplements on vessel wall thromboresistance in patients undergoing cardiac surgery
S J Brister, M R Buchanan
Thrombosis Research
|
September 15, 1998
Inhibition of chronic vessel wall intimal hyperplasia following acute anticoagulant treatment: relative effects of heparin and dermatan sulphate
M R Buchanan, S J Brister
The Canadian Journal of Cardiology
|
March 1, 1995
Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically
M R Buchanan, S J Brister
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Advances in Experimental Medicine and Biology
|
January 1, 1997
Effects of 13-HODE and other momohydroxides on integrin/ligand binding: implications for cell cell interactions
M R Buchanan, S J Brister
Seminars in Thrombosis and Hemostasis
|
January 1, 1993
Altering vessel wall fatty acid metabolism: a new strategy for antithrombotic treatment
M R Buchanan, S J Brister
Thrombosis Research
|
September 7, 2000
Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist
M R Buchanan, S J Brister
Wiener Klinische Wochenschrift
|
March 27, 1999
A rationale for targeting antithrombotic therapy at the vessel wall: improved antithrombotic effect and decreased risk of bleeding
M R Buchanan, S J Brister
Journal of Cardiothoracic and Vascular Anesthesia
|
June 1, 1995
Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate
S J Brister, M R Buchanan
The Canadian Journal of Cardiology
|
December 1, 2001
Sex-related differences in the pathophysiology of cardiovascular disease: is there a rationale for sex-related treatments?
M R Buchanan, S J Brister
The Canadian Journal of Cardiology
|
January 28, 1998
Revascularization options
S J Brister, R G MacDonald
Advances in Experimental Medicine and Biology
|
January 1, 1997
Effects of linoleic acid and/or marine fish oil supplements on vessel wall thromboresistance in patients undergoing cardiac surgery
S J Brister, M R Buchanan
Thrombosis Research
|
September 15, 1998
Inhibition of chronic vessel wall intimal hyperplasia following acute anticoagulant treatment: relative effects of heparin and dermatan sulphate
M R Buchanan, S J Brister
The Canadian Journal of Cardiology
|
March 1, 1995
Individual variation in the effects of ASA on platelet function: implications for the use of ASA clinically
M R Buchanan, S J Brister
Page
of 3